6LU D,SHAO HT,GE WP,et al. Ginsenoside-Rbl and tet- ramethylpyrazine phosphate act synergistically to preventdilated cardiomyopathy in cTnTR141W transgenic mice [J]. J Cardiovasc Pharmacol, 2012,59 (5) :426 - 433.
7ZHANG L, DENG M, ZHOU S, et al. Tetramethylpyrazine inhibitshypoxia-induced pulmonary vascular leakage in rats viathe ROS-HIF-VEGF pathway [J]. Pharmacology, 2011, 87 (5) :265 - 273.
8FAROOQ V, VAN KLAVEREN D, STEYERBERG EW, et al. Anatomical and clinical characteristics to guide deci- sion making between coronary artery bypass surgery and percutaneous coronary intervention for individual" patients: development and validation of SYNTAX score I! [J]. Lancet, 2013,3( 1 ) :639 -650.
9MENTZER RM JR. Myocardial protection in heart surgery [J]. J Cardiovasc Pharmacol Ther, 2011,16 ( 34 ) : 290 - 297.
10URBANOV~ D, URBAN L, CARTER A. Cardiac tro-ponins biochemical markers of cardiac toxicity after cyto- static therapy [J]. Neoplasma,2006,53 (3) : 183 - 190.
